ChemoCentryx, Inc. (CCXI) - Earnings & Price History

CCXI: ChemoCentryx, Inc. - 6.63, $319.51M, 0.06 (0.91%)

Sector: Healthcare - Industry: Biotechnology

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and cancer in the United States. Its lead drug candidates in clinical development include CCX168, which is in Phase II clinical trials for the treatment of orphan and rare diseases; CCX872, which is in Phase Ib clinical trials for the treatment of immuno-oncology diseases; and CCX140 that has completed a Phase II clinical trial for the treatment of chronic kidney diseases. The company is also developing Vercirnon, which is in Phase III clinical trials for the treatment of patients with moderate-to-severe Crohns diseases; CCX507 that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and Th-17 cells for the treatment

Past CCXI reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-14AMC-0.227.316.696.726.687.350.45%8.78%9.27%124.26K
2016-11-07AMC-0.086.836.726.366.266.92-5.36%▲7.39%1.64%292.13K
2016-08-08AMC0.074.244.374.614.164.615.49%-8.03%-2.97%193.70K
2016-05-10AMC-0.274.62.993.022.94.861.00%52.32%53.85%20.65M
2016-05-04AMC-0.272.052.0421.922.14-1.96%2.50%0.49%127.56K
2016-03-14AMC-0.283.013.483.292.973.5-5.46%-8.51%-13.51%176.79K
2015-11-09AMC-0.296.566.676.516.286.57-2.40%▲0.77%-1.65%120.34K
2015-08-06AMC-0.296.687.547.326.437.57-2.92%-8.74%-11.41%187.75K
2015-05-06AMC-0.2876.686.556.557.09-1.95%6.87%4.79%125.54K
2014-11-05AMCChemocentryx-0.29-0.254.845.535.44.755.4-2.35%▲-10.37%-12.48%99.20K
2014-08-05AMCChemocentryx-0.27-0.285.565.515.315.315.59-3.63%4.71%0.91%54.30K
2014-05-08AMCChemocentryx-0.24-0.275.115.395.224.855.36-3.15%-2.11%-5.19%238.40K
2014-03-13AMCChemocentryx-0.24-0.227.136.916.956.797.130.58%2.59%3.18%318.50K
2013-11-07AMCChemocentryx-0.26-0.224.854.674.684.684.990.21%▲3.63%3.85%471.50K
2013-08-12AMCChemocentryx-0.29-0.2312.9412.6612.8312.6513.291.34%0.86%2.21%141.80K
2013-05-13AMC-0.2714.7413.2613.6813.30114.963.17%7.75%11.16%403.71K
2013-03-13AMC-0.2813.951410.910.8714-22.14%27.98%-0.36%130.64K
2012-11-13Chemocentryx-0.2-0.2812.712.3112.312.2812.95-0.08%▲3.25%3.17%433.10K
2012-08-10BMOQ2 2012 ChemoCentryx-0.21-0.311.0212.3312.4610.4913.511.05%-11.56%-10.62%25.70K

Login | Register
Monday Oct 15, 2018   EST
Enter a Ticker:

Economic Calendar

Retail Sales 8:30 AM ET Empire State Mfg Survey 8:30 AM ET Business Inventories 10:00 AM ET 4-Week Bill Announcement 11:00 AM ET 8-Week Bill Announcement 11:00 AM ET 3-Month Bill Auction 11:30 AM ET 6-Month Bill Auction 11:30 AM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades